Published in Mol Med Rep on April 13, 2016
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Coordinated transcription of key pathways in the mouse by the circadian clock. Cell (2002) 14.07
Akt stimulates aerobic glycolysis in cancer cells. Cancer Res (2004) 9.35
Time zones: a comparative genetics of circadian clocks. Nat Rev Genet (2001) 8.98
Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol (2001) 6.76
The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal (2002) 6.35
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell (2002) 6.05
Control mechanism of the circadian clock for timing of cell division in vivo. Science (2003) 5.92
Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature (1997) 4.44
A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell (1999) 4.08
Light-induced resetting of a mammalian circadian clock is associated with rapid induction of the mPer1 transcript. Cell (1997) 3.79
Increased breast cancer risk among women who work predominantly at night. Epidemiology (2001) 2.93
The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell (2006) 2.71
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J (2001) 2.55
Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem (1991) 2.20
FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol (1994) 2.10
Tumor suppression by the mammalian Period genes. Cancer Causes Control (2006) 1.69
Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer (1997) 1.67
FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet (1999) 1.49
A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res (2003) 1.26
MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions. J Biol Chem (2003) 1.07
Circadian variation of cell proliferation and cell cycle protein expression in man: clinical implications. Prog Cell Cycle Res (2000) 1.05
Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat (2008) 1.03
Identification of candidate methylation-responsive genes in ovarian cancer. Mol Cancer (2007) 0.94
Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: correlation with metastasis and invasion. Int J Oral Maxillofac Surg (2008) 0.92
Targeting serine/threonine protein kinase B/Akt and cell-cycle checkpoint kinases for treating cancer. Curr Top Med Chem (2002) 0.90
Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Res Treat (2005) 0.88
Close association of metastasis-associated protein 1 overexpression with increased angiogenesis and poor survival in patients with histologically node-negative gastric cancer. World J Surg (2013) 0.87
Clock genes: their role in colorectal cancer. World J Gastroenterol (2014) 0.86
[Study on the correlationship between the expression of nm23H1mRNA, TGF-beta1mRNA and tumor metastases, survival rate with prostate cancer]. Fen Zi Xi Bao Sheng Wu Xue Bao (2006) 0.85
Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast. Ann Surg Oncol (2012) 0.84
Role of MTA1 in head and neck cancers. Cancer Metastasis Rev (2014) 0.84
Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner. Oncotarget (2015) 0.83
miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion. Acta Biochim Biophys Sin (Shanghai) (2015) 0.81
[Expression and clinical significance of circadian gene Per2 in non-small cell lung cancer]. Zhonghua Zhong Liu Za Zhi (2013) 0.81
H-ras and Nm23-H1 gene expression and proteolytic activity in squamous cell carcinoma of the uterine cervix. Arch Med Res (2000) 0.78
[Relationship between nm23-H1 expression and lymph node metastasis and prognosis in cervical cancer]. Zhonghua Fu Chan Ke Za Zhi (1997) 0.78
Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system. Cancer Metastasis Rev (2014) 0.78
Metastasis suppressors Nm23H1 and Nm23H2 differentially regulate neoplastic transformation and tumorigenesis. Cancer Lett (2015) 0.77
[Research on human ovarian cancer cell MDR1 gene silenced by siRNA]. Sichuan Da Xue Xue Bao Yi Xue Ban (2007) 0.76
Importance of cell kinetics rhythmicity for the control of cell proliferation and carcinogenesis in rat liver (review). In Vivo (1996) 0.76
Epidemiology and outcomes of squamous ovarian carcinoma; a population-based study. Gynecol Oncol (2016) 0.76